Interpreting the Mortality Difference Between Cefepime and Piperacillin-Tazobactam in Pseudomonas aeruginosa Pneumonia
Clinical Infectious Diseases · 16.11.2026
DOI: 10.1093/cid/ciag726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 16.11.2026. Verfasst von Jean Regina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service of Internal Medicine, Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Service of Internal Medicine, Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
- Infectious Diseases Service, Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
- Division of Infectious Diseases, Mayo Clinic Rochester, Rochester MN, USA.
- Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
- Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Canada.
- Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, QC, Canada.
ORCID-Profile: Jean Regina
Zitieren
APA
Regina, J., Brahier, T., Sohani, Z. N., McDonald, E. G., & Lee, T. C. (2026). Interpreting the Mortality Difference Between Cefepime and Piperacillin-Tazobactam in Pseudomonas aeruginosa Pneumonia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag726
Vancouver
Regina J, Brahier T, Sohani ZN, McDonald EG, Lee TC. Interpreting the Mortality Difference Between Cefepime and Piperacillin-Tazobactam in Pseudomonas aeruginosa Pneumonia. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag726
BibTeX
@article{Regina2026,
author = {Regina, Jean and Brahier, Thomas and Sohani, Zahra N and McDonald, Emily G and Lee, Todd C},
title = {Interpreting the Mortality Difference Between Cefepime and Piperacillin-Tazobactam in Pseudomonas aeruginosa Pneumonia},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag726}
}
EUVIMED